Testing effectiveness (Phase 2)Active Not RecruitingNCT02414269
What this trial is testing
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Who this might be right for
Malignant Pleural DiseaseMesotheliomaMetastases+2 more
Memorial Sloan Kettering Cancer Center 113